Skip to main content

Pheochromocytoma and Paraganglioma in the Pediatric Population

  • Chapter
  • First Online:
Pheochromocytomas, Paragangliomas and Disorders of the Sympathoadrenal System

Part of the book series: Contemporary Endocrinology ((COE))

Abstract

Pheochromocytomas and paragangliomas are rare tumors in the pediatric population that arise from neural crest cells. Prompt recognition and treatment are necessary to limit morbidity. Compared to adults, pheochromocytoma and paraganglioma in children are more likely to be associated with an underlying genetic syndrome, and genetic testing should be pursued. These tumors can produce catecholamines and present with symptoms such as sweating, nausea, emesis, hypertension, or diarrhea, or they can be nonfunctional and present with symptoms related to mass effect. Evaluation is initiated with measurement of urine and plasma metanephrines and diagnosis confirmed with magnetic resonance imaging. Definitive treatment occurs via surgical excision. A multidisciplinary team specifically trained in the management of pediatric PHEO and PGL is necessary for optimal patient care.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Beltsevich DG, Kuznetsov NS, Kazaryan AM, Lysenko MA. Pheochromocytoma surgery: epidemiologic peculiarities in children. World J Surg. 2004;28(6):592–6.

    Article  Google Scholar 

  2. Barontini M, Levin G, Sanso G. Characteristics of pheochromocytoma in a 4- to 20-year-old population. Ann N Y Acad Sci. 2006;1073:30–7.

    Article  Google Scholar 

  3. Waguespack SG, Rich T, Grubbs E, et al. A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2010;95(5):2023–37.

    Article  CAS  Google Scholar 

  4. Neumann HP, Bausch B, McWhinney SR, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med. 2002;346(19):1459–66.

    Article  CAS  Google Scholar 

  5. Babic B, Patel D, Aufforth R, et al. Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors. Surgery. 2017;161(1):220–7.

    Article  Google Scholar 

  6. Pamporaki C, Hamplova B, Peitzsch M, et al. Characteristics of Pediatric vs adult Pheochromocytomas and Paragangliomas. J Clin Endocrinol Metab. 2017;102(4):1122–32.

    Article  Google Scholar 

  7. Wyszynska T, Cichocka E, Wieteska-Klimczak A, Jobs K, Januszewicz PA. Single pediatric center experience with 1025 children with hypertension. Acta Paediatr (Oslo, Norway : 1992). 1992;81(3):244–6.

    Article  CAS  Google Scholar 

  8. Grinsell MM, Norwood VF. At the bottom of the differential diagnosis list: unusual causes of pediatric hypertension. Pediatr Nephrol (Berlin, Germany). 2009;24(11):2137–46.

    Article  Google Scholar 

  9. Pham TH, Moir C, Thompson GB, et al. Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center. Pediatrics. 2006;118(3):1109–17.

    Article  Google Scholar 

  10. Sullivan J, Groshong T, Tobias JD. Presenting signs and symptoms of pheochromocytoma in pediatric-aged patients. Clin Pediatr. 2005;44(8):715–9.

    Article  Google Scholar 

  11. Bausch B, Wellner U, Bausch D, et al. Long-term prognosis of patients with pediatric pheochromocytoma. Endocr Relat Cancer. 2014;21(1):17–25.

    Article  Google Scholar 

  12. Barontini M, Dahia PL. VHL disease. Best Pract Res Clin Endocr Metab. 2010;24(3):401–13.

    Article  CAS  Google Scholar 

  13. Aufforth RD, Ramakant P, Sadowski SM, et al. Pheochromocytoma screening initiation and frequency in von Hippel-Lindau syndrome. J Clin Endocrinol Metab. 2015;100(12):4498–504.

    Article  CAS  Google Scholar 

  14. Glasker S, Neumann HPH, Koch CA, Vortmeyer AO. Von Hippel-Lindau disease. In: De Groot LJ, Chrousos G, Dungan K, et al., editors. Endotext. South Dartmouth: MDText.com, Inc.; 2000.

    Google Scholar 

  15. Kirmani S, Young WF. Hereditary paraganglioma-pheochromocytoma syndromes. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews(R). Seattle: University of Washington, Seattle University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved; 1993.

    Google Scholar 

  16. Gruber LM, Erickson D, Babovic-Vuksanovic D, Thompson GB, Young WF Jr, Bancos I. Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1. Clin Endocrinol. 2017;86(1):141–9.

    Article  CAS  Google Scholar 

  17. Bausch B, Borozdin W, Clinical NHP. Genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma. N Engl J Med. 2006;354(25):2729–31.

    Article  CAS  Google Scholar 

  18. Marquard J, Eng C. Multiple endocrine neoplasia type 2. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews(R). Seattle: University of Washington, Seattle University of Washington, Seattle. All rights reserved; 1993.

    Google Scholar 

  19. Pacak K, Ilias I, Adams KT, Eisenhofer G. Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour. J Intern Med. 2005;257(1):60–8.

    Article  CAS  Google Scholar 

  20. Eng C, Clayton D, Schuffenecker I, et al. The relationship between specific RET proto- oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA. 1996;276(19):1575–9.

    Article  CAS  Google Scholar 

  21. Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915–42.

    Article  CAS  Google Scholar 

  22. Weismann D, Peitzsch M, Raida A, et al. Measurements of plasma metanephrines by immunoassay vs liquid chromatography with tandem mass spectrometry for diagnosis of pheochromocytoma. Eur J Endocrinol. 2015;172(3):251–60.

    Article  CAS  Google Scholar 

  23. Parra A, Ramirez del Angel A, Cervantes C, Sanchez M. Urinary excretion of catecholamines in healthy subjects in relation to body growth. Acta Endocrinol. 1980;94(4):546–51.

    CAS  PubMed  Google Scholar 

  24. Weise M, Merke DP, Pacak K, Walther MM, Eisenhofer G. Utility of plasma free metanephrines for detecting childhood pheochromocytoma. J Clin Endocrinol Metab. 2002;87(5):1955–60.

    Article  CAS  Google Scholar 

  25. Grossrubatscher E, Dalino P, Vignati F, et al. The role of chromogranin a in the management of patients with phaeochromocytoma. Clin Endocrinol. 2006;65(3):287–93.

    Article  CAS  Google Scholar 

  26. Bilek R, Safarik L, Ciprova V, Vlcek P, Lisa L, Chromogranin A. A member of neuroendocrine secretory proteins as a selective marker for laboratory diagnosis of pheochromocytoma. Physiol Res. 2008;57(Suppl 1):S171–9.

    CAS  PubMed  Google Scholar 

  27. Chrisoulidou A, Kaltsas G, Ilias I, Grossman AB. The diagnosis and management of malignant phaeochromocytoma and paraganglioma. Endocr Relat Cancer. 2007;14(3):569–85.

    Article  CAS  Google Scholar 

  28. Hack HA. The perioperative management of children with phaeochromocytoma. Paediatr Anaesth. 2000;10(5):463–76.

    Article  CAS  Google Scholar 

  29. Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab. 2007;92(11):4069–79.

    Article  CAS  Google Scholar 

  30. Ludwig AD, Feig DI, Brandt ML, Hicks MJ, Fitch ME, Cass DL. Recent advances in the diagnosis and treatment of pheochromocytoma in children. Am J Surg. 2007;194(6):792–6. discussion 796–7

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rachel Kadakia .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kadakia, R., Bianco, M., Dabrowski, E., Zimmerman, D. (2018). Pheochromocytoma and Paraganglioma in the Pediatric Population. In: Landsberg, L. (eds) Pheochromocytomas, Paragangliomas and Disorders of the Sympathoadrenal System. Contemporary Endocrinology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-77048-2_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-77048-2_5

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-77047-5

  • Online ISBN: 978-3-319-77048-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics